Angioplasty Current Events | Angioplasty News | 5
|
|
|
Sort By:
Page Views | Date |
For high-risk patients, stroke-prevention surgical procedure does not equate with high surgical risk
New research published in the August issue of the Journal of the American College of Surgeons shows that "high-risk" patients with multiple medical conditions, including high blood pressure and coronary artery disease, can safely undergo carotid endarterectomy - a stroke-preventing surgical procedure that clears blockages from the neck's... view more... (2008-08-14)
New strategies for reperfusion therapy
A new trial has begun in order to ascertain once and for all whether the best strategy for patients who cannot receive P-PCI is early fibrinolysis, together with mandated angiography. view more (2009-08-31)
Dual treatment for stroke leads to improved recovery rates, reduced mortality
It appears that stroke patients who receive both intravenous thrombolysis - a minimally invasive treatment that dissolves abnormal blood clots - and endovascular interventions - such as drugs and implanting medical devices - are much more likely to recover and have lower chances of dying. view more (2008-11-13)
Comparison of drug-releasing coronary stents show similar effectiveness
Use of coronary stents that release the drugs sirolimus or paclitaxel produced similar results in patients with new coronary artery lesions, according to a study in the February 22 issue of JAMA. view more (2006-02-22)
Fewer adverse cardiac events at one year
Late breaking results from the SPIRIT III trial, presented at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation, show that after 12 months, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the... view more... (2007-10-24)
Poor people worse off following heart attack
People from lower socioeconomic backgrounds who suffer a heart attack come to the emergency department more often, are less likely to be treated aggressively and have higher mortality rates a year after the attack. view more (2007-02-14)
FSU researcher's 'mutant' proteins could lead to new treatment for heart disease
Heart damage due to blocked arteries remains the leading cause of disease and death in the Western world, but a Florida State University College of Medicine researcher is helping to open new pathways toward treating the problem. view more (2008-03-25)
Patients who receive drug-eluting stents should continue antiplatelet medications
Patients who have had drug-eluting stents inserted to prop open blocked coronary arteries should continue to take medications to reduce the risk of blood clots for at least one year after the stent is inserted, a new scientific advisory recommends. view more (2007-01-17)
Heart care lacking for those with clogged leg blood vessels
Despite the fact that clogged arteries in the legs usually mean clogged arteries near the heart, doctors often fail to give heart-protecting drugs to people with severe leg blood vessel blockages, a new University of Michigan-led study finds. view more (2005-11-16)
NEW THERAPEUTIC APPROACH TO CORONARY STENTING (p 2037)
Patients given stent implantation to treat coronary heart disease could benefit from a new therapeutic approach with the platelet glycoprotein IIb/IIIa inhibitor eptifibatide, concludes research published in this week's issue of THE LANCET. The platelet glycoprotein IIb/IIIa inhibitors are potent inhibitors of blood clotting. They have previously... view more... (2000-12-13)
Irregular heart rhythm before or after cardiac catheterization linked to risk of death
Certain heart attack patients who experience a rapid, abnormal heart rhythm before or after a coronary artery intervention or stent placement have a significantly higher risk of death within 90 days of the procedure. view more (2009-05-06)
ALTERNATIVE PHARMACOLOGICAL STRATEGY FOR TREATMENT OF ACUTE HEART ATTACK (pp 1898, 1905)
Results of the GUSTO V randomised trial - detailed in a fast-track study in this week's issue of THE LANCET - suggest a role for a combination drug strategy for the treatment of acute heart attack. Despite having been the standard of care for acute myocardial infarction (heart attack) since the 1980s, reperfusion (re-establishing blood flow to the... view more... (2001-06-13)
New data examine stents and bypass surgery in patients with 3VD and LMD
Newly reported data presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF) from the SYNTAX clinical trial (SYNergy Between PCI With TAXUS and Cardiac Surgery) reveal similar safety and efficacy outcomes when the use of a drug-eluting stent is... view more... (2008-10-15)
Novel compound may lessen heart attack damage
A novel drug designed to lessen muscle damage from a heart attack has passed initial safety tests at the Duke Clinical Research Institute. Results of the study, available online and to be published in the February 19 issue of the journal Circulation, reflect the first time the drug has been tested in humans. view more (2008-02-07)
ESC Congress 2003: New drug-eluting stents: enthusiasm sobered by economic constraints
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Drug-eluting stents - a universal panacea A huge wave of... view more... (2003-09-02)
|
|
|
|
Sort By:
Page Views | Date |
|
